G80.2
Conditions
Interventions
Group 1: Phase A - week 1: In addition to the regular rehabilitation program study participants will undergo 10 sessions of physiotherapy focusing on dorsiflexion
exercises are chosen on the concept of motor learning. Each session will last 15 minutes. Each day 2 sessions will take place (in the morning and the afternoon).
Week 2 - "Pause" - no specific train
exercises are chosen on the concept of motor learning. Each session will last 15 minutes. Each day 2 sessions will take place (in the morning and the afternoon).
Sponsors
Fachzentrum für Pädiatrische Neurologie, Neurorehabilitation und Epilepsie, Schön Klinik Vogtareuth
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: Congenital or acquired brain injury (> 12 months ago) Cerebral Palsy GMFCS Level I or II or III Age between 6 and 17 years Dorsiflexor weakness (Medical Research Conucil Score 1) Admission for at least 3 week to the reabilitation clinic (inpatient setting)
Exclusion criteria
Exclusion criteria: Confirmed intellectual disability, defined by IQ < 70 Confirmed attention deficit disorder (F90-F98, ICD 10) Severe impairment of communication (CFCS Level III, IV, V) Treatment with Botulinumtoxin or orthopedic operation of the lower extremity within the past 3 months Contraindication for a treatment with magnetic stimulation • Confirmed epilepsy • Ferromagnetic (metal) parts in or on the body (e.g. piercings, intrauterine spiral, vascular clamps) • Biomedical implanted shunt-systems (e.g. ventriculo-peritoneal shunt) • Biomedical implanted devices (e.g. cochlear implant, medication pump, heart or brain pacemaker) • Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients that take part in at least 9 of 10 scheduled treamtent sessions. Further questions adressing adherence rate: what are the reasons for discontinuation of treatment? What would be reasons to not recommend the treatment to other patients and their parents? | — |
Secondary
| Measure | Time frame |
|---|---|
| Clincal effects: Evaluation on an individual basis in terms of clinical assessments during 4 timepoints. Recruiting rate: Proportion of eligible paitents, that take part in the study Safety: Reporting fo adverese events Satisfaction: Are patients and parents satisfied with the treatment Feasibility from the physiotherapist's perspective after the invertention period | — |
Countries
Germany
Contacts
Public ContactSteffen Berweck
Fachzentrum für Pädiatrische Neurologie, Neurorehabilitation und Epilepsie, Schön Klinik Vogtareuth
Outcome results
None listed